DEXA Body Composition Interpretation by Decade of Life

Why DEXA Beats BMI for Body Composition Assessment

BMI tells you nothing about what you are made of. DEXA separates your body into three compartments: fat mass, lean soft tissue, and bone mineral content, each measured in grams per region. Two patients at identical BMI can differ by 15 percentage points of body fat, a gap that carries opposite cardiovascular risk trajectories. A 2021 analysis in the Journal of the American Heart Association found that normal-weight obesity (BMI <25 but high fat mass on DEXA) independently predicted a 2.1-fold increase in all-cause mortality risk compared with normal-weight, normal-fat individuals. [1]

How the Machine Works

DEXA fires two low-energy X-ray beams at different kiloelectron-volt levels through your body. Bone, lean tissue, and fat attenuate the beams differently. Software reconstructs regional maps, producing the printout your clinician reviews. Scan time is roughly 10 to 15 minutes. Radiation exposure is 1 to 6 µSv, far below the 80 µSv from a cross-country flight.

Which Numbers to Read First

Most DEXA printouts overwhelm patients with a grid of numbers. Prioritize in this order: appendicular lean mass index (ALMI), visceral fat area or mass, total body fat percentage, and android-to-gynoid fat ratio. Bone mineral density is the fifth column; it matters independently but is discussed in its own section below.

Precision and the Minimum Detectable Change

The precision error of DEXA for fat mass is roughly 2 to 3% in experienced centers. The International Society for Clinical Densitometry (ISCD) recommends using least significant change (LSC) calculations at each facility before comparing serial scans. [2] A reported change smaller than the LSC is noise, not biology. Ask your imaging center for its published LSC before attributing a 1 kg lean mass shift to your new training program.

The Metrics That Matter Most Across All Decades

Before walking through decade-specific ranges, understanding each metric's clinical meaning prevents misreading a printout.

Appendicular Lean Mass Index (ALMI)

ALMI equals the sum of arm and leg lean mass (kg) divided by height in meters squared. It is the preferred screening variable for sarcopenia per the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) consensus. EWGSOP2 defines probable sarcopenia when ALMI falls below 7.0 kg/m² in men and below 5.5 kg/m² in women. [3] These thresholds were derived from populations two standard deviations below young adult reference means.

Visceral Adipose Tissue (VAT)

Visceral fat is metabolically active in ways subcutaneous fat is not. It secretes interleukin-6, tumor necrosis factor-alpha, and free fatty acids directly into portal circulation. A 2019 study in Obesity (N=3,289) found that visceral fat area above 100 cm² on DEXA associated with a 3.4-fold higher prevalence of metabolic syndrome regardless of total body fat percentage. [4] Your DEXA report may express this as a visceral fat mass in grams or an estimated area in cm².

Android-to-Gynoid Fat Ratio

Android fat (chest, abdomen, upper body) divided by gynoid fat (hips, thighs) gives a ratio linked to insulin resistance independent of total fat. Research published in PLOS ONE (N=15,184 NHANES participants) showed android-to-gynoid ratio above 1.0 in men and above 0.8 in women correlated with elevated fasting glucose, triglycerides, and blood pressure. [5]

Total Body Fat Percentage

Body fat percentage is the most commonly reported number but the easiest to misinterpret without age and sex context. The American Council on Exercise (ACE) publishes reference ranges stratified by sex; at any given percentage, a 25-year-old and a 65-year-old face different health implications because lean mass and bone density shift the metabolic picture.

Decade-by-Decade Interpretation

Your 20s: Establish the Baseline

Ages 20 to 29 represent peak lean mass for most people. Cross-sectional NHANES data show men in this decade average total body fat of 18 to 23% and women average 24 to 31% by DEXA. [6] ALMI in a healthy 25-year-old man typically sits between 8.5 to 10.0 kg/m²; in women, 6.5 to 8.0 kg/m².

What to Watch in Your 20s

Visceral fat is the early warning signal even at low total body fat. A lean 24-year-old with VAT above 100 cm² warrants metabolic investigation. Android-to-gynoid ratio above 1.0 in a man or above 0.8 in a woman in their 20s predicts insulin resistance years before fasting glucose rises. Establish a baseline scan in this decade if you have a family history of type 2 diabetes, metabolic syndrome, or early cardiovascular disease.

Optimal Targets at Ages 20 to 29

Optimal body fat percentage: 10 to 18% for men, 20 to 28% for women (performance-health intersection). ALMI at or above the sex-specific 50th percentile of young adult norms. VAT area below 50 cm². Android-to-gynoid ratio below 0.85 for men, below 0.72 for women.

Your 30s: The First Inflection Point

Lean mass velocity begins declining after age 30 at roughly 0.5 to 1.0% per year without deliberate resistance training. A longitudinal study in the American Journal of Clinical Nutrition tracked 468 adults across 12 years and found men lost a mean of 0.23 kg of appendicular lean mass per year from ages 30 to 41. [7] Fat mass tends to redistribute centrally even when scale weight stays stable.

GLP-1 Prescribers: Monitor Lean Mass Here First

If a patient in their 30s starts semaglutide or tirzepatide, baseline DEXA before treatment is the standard of care at HealthRX. The STEP-1 trial (N=1,961) showed that semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks, but sub-analyses indicate approximately 39% of the weight lost was fat-free mass in participants not on structured resistance training. [8] Losing lean mass in your 30s compounds the natural age-related decline that accelerates in the next two decades.

Normal and Optimal Ranges at Ages 30 to 39

Normal body fat: 19 to 25% for men, 25 to 33% for women. Optimal: men 12 to 20%, women 18 to 26%. ALMI should remain above the 40th percentile of young-adult norms. A drop of more than 0.3 kg/m² in ALMI between two scans 6 months apart merits a protein intake and resistance-training review.

Your 40s: Hormonal Shifts Change the Math

Testosterone in men declines at roughly 1 to 2% per year after 40. Perimenopause in women begins, on average, around age 47. Both shifts accelerate visceral fat accumulation and blunt muscle protein synthesis. A study in the Journal of Clinical Endocrinology and Metabolism (N=858 men, mean follow-up 4.3 years) found that free testosterone below 70 pg/mL associated with a 4.4 kg greater gain in fat mass and 1.1 kg greater loss in lean mass over the follow-up period. [9]

Reading DEXA in the Context of Hormone Therapy

Men on testosterone replacement therapy (TRT) should repeat DEXA at 6 months after stable dosing. A well-dosed TRT protocol typically produces a 1 to 2 kg increase in ALMI and a 1 to 2 kg reduction in fat mass within 12 months in hypogonadal men, according to data from the Testosterone Trials (TTrials). Women beginning estrogen-plus-progesterone HRT may see redistribution from android to gynoid depots within 12 to 18 months; the android-to-gynoid ratio is the most sensitive DEXA marker of this shift.

Normal and Optimal Ranges at Ages 40 to 49

Normal body fat: 21 to 27% for men, 27 to 35% for women. Optimal: men 14 to 22%, women 20 to 30%. VAT area should remain below 100 cm². Any ALMI below 7.5 kg/m² in a 45-year-old man warrants a dedicated sarcopenia workup including grip strength and 4-meter gait speed.

Your 50s: Accelerated Sarcopenic Risk

Muscle protein synthesis response to feeding drops sharply after 50, a phenomenon sometimes called "anabolic resistance." A Nutrients review of 49 controlled trials found that protein intake above 1.6 g/kg/day preserved significantly more lean mass during energy restriction in adults aged 50 to 65 than intakes at the RDA of 0.8 g/kg/day. [10] DEXA in this decade must track ALMI as the primary outcome, not total body weight.

Bone Mineral Density Diverges from Lean Mass

Postmenopausal women lose 1 to 3% of bone mineral density per year in the first 5 to 10 years after menopause. The National Osteoporosis Foundation (part of the Bone Health and Osteoporosis Foundation) states that a T-score below negative 2.5 defines osteoporosis and below negative 1.0 defines osteopenia. [11] Clinicians monitoring lean mass with DEXA should simultaneously check T-scores at the femoral neck and lumbar spine at every scan in this decade.

Normal and Optimal Ranges at Ages 50 to 59

Normal body fat: 22 to 28% for men, 28 to 38% for women (reflecting age-adjusted norms). Optimal for metabolic health: men 15 to 22%, women 22 to 32%. ALMI below 7.0 kg/m² in men or 5.5 kg/m² in women at this age calls for a combined intervention: resistance training at least 3 days per week, protein at 1.6 to 2.0 g/kg/day, and hormonal evaluation.

Your 60s: Sarcopenia Becomes the Primary Risk

Sarcopenia affects an estimated 5 to 13% of adults aged 60 to 70 and rises to 11 to 50% by age 80, depending on diagnostic criteria. A 2014 meta-analysis in Age and Ageing (27 studies, N=58,404) found sarcopenia associated with a 2.34 relative risk of all-cause mortality in community-dwelling adults. [12] At this age, gaining 0.5 kg of lean mass may carry more clinical value than losing 2 kg of fat mass.

DEXA Metrics to Prioritize After 60

ALMI takes priority. Target ALMI above 7.0 kg/m² for men and above 5.5 kg/m² for women to stay outside EWGSOP2 sarcopenia thresholds. Body fat percentage norms widen: 23 to 30% for men and 30 to 40% for women fall within the broadly accepted normal range for this decade. Optimal is not always the same as lowest. Excess fat loss without lean preservation in a 65-year-old accelerates the sarcopenic trajectory.

Using DEXA to Guide GLP-1 Monitoring in Older Adults

Adults aged 60 and older on GLP-1 receptor agonists are at the highest risk of lean mass loss from pharmacologic caloric restriction. HealthRX protocol requires DEXA at baseline, 3 months, and 6 months in this age group. Any decline in ALMI greater than the LSC triggers a protein and resistance-training protocol adjustment before the next prescription refill.

Your 70s and Beyond: Preservation Over Optimization

Body composition goals shift from optimization to preservation in the eighth decade and beyond. A 2019 analysis of the Health ABC cohort (N=2,292, mean age 73.6) found that losing more than 5% of lean mass over 2 years was associated with a 1.58 hazard ratio for incident mobility disability independent of fat mass change. [13]

What "Normal" Looks Like After 70

Body fat percentages of 25 to 33% in men and 32 to 42% in women fall within published age-specific normal ranges. Low body fat in this decade is not protective. Fat mass below 18% in a 75-year-old man may signal malnutrition, cancer cachexia, or frailty rather than fitness achievement. ALMI below 6.5 kg/m² in men or 4.8 kg/m² in women at age 75 predicts fall risk and should trigger a formal geriatric frailty assessment.

Serial DEXA Scheduling After 70

Scan every 12 months if body composition is stable. Scan every 6 months if the patient is on a GLP-1, is recovering from a hospitalization, or has lost more than 3% of body weight unintentionally. Bone mineral density scan should accompany lean mass assessment at every visit in this age group.

DEXA and GLP-1 Therapy: A Specific Protocol

GLP-1 receptor agonists and dual GIP/GLP-1 agonists (tirzepatide) produce substantial weight loss but carry a well-documented lean mass erosion risk. The SURMOUNT-1 trial (N=2,539) reported 20.9% mean body weight loss with tirzepatide 15 mg at 72 weeks; body composition sub-studies found roughly 33 to 40% of weight lost was fat-free mass in participants not on supervised exercise programs. [14]

Why Lean Mass Loss Matters More Than the Scale

Every kilogram of muscle lost reduces resting metabolic rate by roughly 13 kcal/day and decreases insulin-mediated glucose disposal. Losing 4 kg of lean mass during a 20 kg weight-loss course adds up to a 52 kcal/day metabolic penalty that makes weight maintenance harder post-treatment.

HealthRX DEXA Monitoring Protocol for GLP-1 Patients

Baseline scan before the first prescription. Repeat at 3 months. Adjust protein and resistance training based on ALMI trajectory. Repeat at 6 months and every 6 months thereafter while on therapy. If ALMI drops more than the facility-specific LSC at any scan, add a creatine monohydrate protocol (3 to 5 g/day) and increase resistance training to at least 3 sessions per week before considering dose escalation.

Reference Ranges Summary Table by Decade

| Age Decade | Body Fat % Men (Normal) | Body Fat % Men (Optimal) | Body Fat % Women (Normal) | Body Fat % Women (Optimal) | ALMI Men Target (kg/m²) | ALMI Women Target (kg/m²) | |---|---|---|---|---|---|---| | 20 to 29 | 18 to 23% | 10 to 18% | 24 to 31% | 20 to 28% | 8.5 to 10.0 | 6.5 to 8.0 | | 30 to 39 | 19 to 25% | 12 to 20% | 25 to 33% | 18 to 26% | 8.0 to 9.5 | 6.2 to 7.8 | | 40 to 49 | 21 to 27% | 14 to 22% | 27 to 35% | 20 to 30% | 7.5 to 9.0 | 6.0 to 7.5 | | 50 to 59 | 22 to 28% | 15 to 22% | 28 to 38% | 22 to 32% | 7.0 to 8.5 | 5.7 to 7.2 | | 60 to 69 | 23 to 30% | 16 to 24% | 30 to 40% | 24 to 34% | 7.0 to 8.0 | 5.5 to 7.0 | | 70+ | 25 to 33% | preserve >18% | 32 to 42% | preserve >24% | maintain >6.5 | maintain >4.8 |

Sources: NHANES DEXA reference data [6], EWGSOP2 consensus [3], ACE body fat classification.

Bone Mineral Density: Reading T-Scores and Z-Scores

DEXA reports both T-scores (comparison to young adult peak bone mass) and Z-scores (comparison to age-matched peers). The ISCD recommends using Z-scores, not T-scores, to interpret bone mineral density in premenopausal women and men under 50, because T-score thresholds derived from postmenopausal women do not apply to younger populations. [2]

A T-score of negative 2.5 or below at any site defines osteoporosis. Negative 1.0 to negative 2.5 defines osteopenia. In a patient on long-term GLP-1 therapy, reduced caloric intake may lower calcium absorption; checking bone mineral density annually in this group is clinically justified. FDA prescribing information for semaglutide (Ozempic, Wegovy) does not list osteoporosis as a labeled risk, but observational data suggest weight loss exceeding 15% of body weight without resistance training associates with measurable bone mineral density decline. [15]

How to Request and Interpret Your DEXA Report

What to Ask the Technician

Request a full-body composition scan, not just a bone density scan. The two are different protocols on the same machine. Specify that you want regional analysis including android, gynoid, trunk, and appendicular compartments. Ask for visceral fat estimation. Not every center offers this by default.

Reading the Printout Yourself

The first page typically shows a body silhouette with regional fat and lean mass in grams. Ignore the silhouette graphics. Read the numerical table: total fat mass (kg and %), total lean mass (kg), ALMI (calculated or ask your physician to calculate it from the arm and leg lean columns divided by height squared), VAT area or mass, and T-scores or Z-scores at the femoral neck and lumbar spine.

When to Repeat

Repeat DEXA in 6 months if you are actively changing body composition through medication, surgery, or a new training program. Twelve months is sufficient for annual monitoring in stable patients. Shorter intervals do not produce changes large enough to exceed the precision error of the machine, and the data will mislead rather than guide.